FDA early alert links four deaths to a Lumify prompt that blocks scanning

MedDevice Startups Staff · Oct 9 · 2 min read · Via FDA early alert

FDA posted an early alert on October 9 for the Philips Lumify handheld ultrasound system. Philips reported eight serious injuries and four deaths associated with the problem as of September 29.

The Lumify app can stop recognizing a transducer it has already registered. It then prompts the user to register again, with no warning, and scanning stays blocked until registration finishes. Registration needs Wi-Fi or cellular service. Philips has reports of the prompt stopping a scan and delaying care in pre-hospital settings. A second issue covers the USB connection between the transducer and the phone or tablet, which can disconnect or run unstable during use.

Affected software runs from iOS 2.x through 5.1.3 and Android 1.x through 5.1.1. Philips sent its letter to customers on September 24. It is building a software update for the registration fault and is still assessing the cause of the cable problem. Until then, Philips and FDA say to use the system only where signal is available, unless a backup ultrasound is immediately at hand.

A registration check that gates the clinical function belongs in the hazard analysis, not only in the product requirements. A device sold for ambulance, aircraft and field use inherits network availability as a use environment assumption.

Questions & Answers

What is the FDA early alert about the Philips Lumify ultrasound system?

On October 9, 2026, FDA issued an early alert about the Philips Lumify handheld ultrasound system. A software fault can make the Lumify app stop recognizing an already registered transducer and demand re-registration, which blocks scanning until it completes.

How many injuries and deaths has Philips reported for the Lumify problem?

As of September 29, 2026, Philips reported eight serious injuries and four deaths associated with the Lumify registration and cable connection problems.

What does FDA recommend for Philips Lumify users?

FDA and Philips recommend using the Philips Lumify system only where Wi-Fi or cellular service is readily available, unless a backup ultrasound device is immediately at hand. Philips is developing a software update for the registration fault.

← Back to Regulatory